Phase 1 Lyme Disease Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
Human Immune Response to Ixodes Scapularis Tick Bites
Lyme DiseaseTick-Borne DiseasesTick Resistance
National Institute of Allergy and Infectious Diseases (NIAID)60 enrolled1 locationNCT05036707
Recruiting
Phase 1Phase 2
Ceftriaxone for Post-Treatment Lyme Disease
Post-treatment Lyme Disease Syndrome
Hackensack Meridian Health20 enrolled1 locationNCT06785402
Recruiting
Phase 1Phase 2
Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Myalgic EncephalomyelitisChronic Fatigue SyndromePost-treatment Lyme Disease Syndrome+1 more
Icahn School of Medicine at Mount Sinai120 enrolled1 locationNCT06511050